Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,500 shares at $68.08 ($506K) on 2014-05-14, disclosed to the SEC on 2014-05-16.
Scheduled sale ($506k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.13 | 500 | $33K | 6.5% |
| 2 | $67.49 | 6,400 | $432K | 85.4% |
| 3 | $68.08 | 600 | $41K | 8.1% |
| Total | $67.45 avg | 7,500 | $506K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |